Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
In this giving season, we thank you for your generosity. Your donation helps thousands of people living with cancer become educated about their disease.
Through this unprecedented year, GRACE has persevered. We are continuing to bring you the most current and emerging educational content to help you in your cancer journey.
We continue to work to fulfill our mission, and believe that Education is Medicine, perhaps more now than ever. Empowering you to be a partner in your medical care through education about treatment options is an absolute necessity. We are honored to be that platform for you.
We are excited about what the next year will bring, with new programs in the works, providing up to date information in the rapidly changing world of medicine. We continue to provide critical educational information to enable patients, families and caregivers to discuss management options with their medical team.
We don't hold golf tournaments or galas to support our work, we depend on your support during our yearly End of Year Appeal. Please consider supporting us again this year. We need your support so that we can continue to provide the most current and emerging treatment options for cancer patients.
Please ~ take this time to donate. Click here to donate online.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…